To Assess the Anti-anginal Safety and Efficacy of Ivabradine in Subjects With Stable，Symptomatic Chronic Angina
Clinical trial NCT02623569 · UNKNOWN
Trial details
- NCT number
- NCT02623569
- Sponsor
- Xintong Pharmacy Company
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2017-06-01
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.